SURROGATE END-POINT USE IN CARDIOVASCULAR CLINICAL-TRIALS

被引：0
|
作者：
PROBSTFIELD, JL [1 ]
YUSUF, S [1 ]
FRIEDMAN, LM [1 ]
LABARTHE, DR [1 ]
BRISTOW, JD [1 ]
WITTES, J [1 ]
机构：
[1] NHLBI,BETHESDA,MD 20205
来源：
CONTROLLED CLINICAL TRIALS | 1986年 / 7卷 / 03期
关键词：
D O I：
10.1016/0197-2456(86)90092-9
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：241 / 242
页数：2
相关论文
共 50 条
  • [1] SURROGATE END-POINT BIOMARKER ASSAYS IN PHASE-II CHEMOPREVENTION CLINICAL-TRIALS
    LIPKIN, M
    BHANDARI, M
    HAKISSIAN, M
    CROLL, W
    WONG, G
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 47 - 54
  • [2] CONSIDERATIONS IN CHOICE OF A CLINICAL END-POINT FOR AIDS CLINICAL-TRIALS
    NEATON, JD
    WENTWORTH, DN
    RHAME, F
    HOGAN, C
    ABRAMS, DI
    DEYTON, L
    [J]. STATISTICS IN MEDICINE, 1994, 13 (19-20) : 2107 - 2125
  • [3] Protein C as a surrogate end-point for clinical trials of sepsis
    Liu, Kathleen D.
    Matthay, Michael A.
    [J]. CRITICAL CARE, 2008, 12 (02):
  • [4] Protein C as a surrogate end-point for clinical trials of sepsis
    Kathleen D Liu
    Michael A Matthay
    [J]. Critical Care, 12
  • [5] USE OF B-MODE ULTRASOUND OF PERIPHERAL ARTERIES AS AN END-POINT IN CLINICAL-TRIALS
    EBRAHIM, S
    [J]. BRITISH HEART JOURNAL, 1994, 72 (06): : 501 - 503
  • [6] MORBIDITY OR MORTALITY AS END-POINT FOR CLINICAL-TRIALS IN INTENSIVE-CARE
    DECRUYENAERE, J
    DEDEYNE, C
    POELAERT, J
    COLARDYN, F
    [J]. LANCET, 1995, 345 (8955): : 986 - 987
  • [7] THE IMPACT OF END-POINT MEASURES IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS
    VANDERHEIDE, A
    JACOBS, JWG
    DINANT, HJ
    BIJLSMA, JWJ
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1992, 21 (05) : 287 - 294
  • [8] DO WE NEED A NEW END-POINT IN CLINICAL-TRIALS TODAY
    GANZ, PA
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (14) : 1105 - 1106
  • [9] CHEMOPREVENTION TRIALS AND SURROGATE END-POINT BIOMARKERS IN THE CERVIX
    MITCHELL, MF
    HITTELMAN, WK
    LOTAN, R
    NISHIOKA, K
    TORTOLEROLUNA, G
    RICHARDSKORTUM, R
    WHARTON, JT
    HONG, WK
    [J]. CANCER, 1995, 76 (10) : 1956 - 1977
  • [10] DO WE NEED A NEW END-POINT IN CLINICAL-TRIALS TODAY - RESPONSE
    SKEEL, RT
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (14) : 1107 - 1107
12345